{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:16:17Z","timestamp":1761765377106,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":1821,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council","doi-asserted-by":"crossref","award":["NSC 97-2314-B-182A-054-MY2"],"award-info":[{"award-number":["NSC 97-2314-B-182A-054-MY2"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"crossref","award":["CMRPG860421 and CMRPG860422"],"award-info":[{"award-number":["CMRPG860421 and CMRPG860422"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.jmii.2011.01.010","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T07:10:50Z","timestamp":1294989050000},"page":"52-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Etanercept treatment for children with refractory juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"44","author":[{"given":"Ho-Chang","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Ren","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Sai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuender D.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2011.01.010_bib1","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jmii.2011.01.010_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4615-4857-7_5","article-title":"Prognosis in juvenile arthritis","volume":"455","author":"Ansell","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jmii.2011.01.010_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0733-8635(05)70254-0","article-title":"Management of collagen vascular diseases in childhood","volume":"16","author":"DeSilva","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jmii.2011.01.010_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1542\/peds.109.1.109","article-title":"Current treatment of juvenile rheumatoid arthritis","volume":"109","author":"Ilowite","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jmii.2011.01.010_bib5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/ard.2005.047225","article-title":"Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis","volume":"65","author":"Tynjala","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jmii.2011.01.010_bib6","first-page":"1238","article-title":"Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis","volume":"28","author":"Moreland","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jmii.2011.01.010_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2011.01.010_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-3038.2008.00779.x","article-title":"Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease","volume":"20","author":"Kuo","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jmii.2011.01.010_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/art.1780370304","article-title":"Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology","volume":"37","author":"Kremer","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jmii.2011.01.010_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-857X(21)00061-2","article-title":"Methotrexate: adverse reactions and major toxicities","volume":"20","author":"Goodman","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jmii.2011.01.010_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0049-0172(97)80021-2","article-title":"Is methotrexate oncogenic in patients with rheumatoid arthritis?","volume":"26","author":"Kremer","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jmii.2011.01.010_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarcon","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmii.2011.01.010_bib13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198605153142001","article-title":"Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial","volume":"314","author":"Brewer","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2011.01.010_bib14","first-page":"1240","article-title":"Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open label extension trial","volume":"18","author":"Giannini","year":"1991","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jmii.2011.01.010_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.1780310103","article-title":"Characteristics of responders and nonresponders to slow-acting antirheumatic drugs in juvenile rheumatoid arthritis","volume":"31","author":"Giannini","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jmii.2011.01.010_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/art.1780330402","article-title":"Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children\u2019s Study Group","volume":"33","author":"Giannini","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jmii.2011.01.010_bib17","first-page":"1604","article-title":"Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis","volume":"19","author":"Wallace","year":"1992","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jmii.2011.01.010_bib18","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jmii.2011.01.010_bib19","first-page":"2481","article-title":"Etanercept treatment improves longitudinal growth in prepubertal children with juvenile idiopathic arthritis","volume":"34","author":"Vojvodich","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jmii.2011.01.010_bib20","first-page":"444","article-title":"Etanercept therapy in children with juvenile rheumatoid arthritis","volume":"38","author":"Hung","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2011.01.010_bib21","first-page":"447","article-title":"Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan\u2014a preliminary report","volume":"38","author":"Liang","year":"2005","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211000119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211000119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:15:15Z","timestamp":1761657315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118211000119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1684118211000119"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2011.01.010","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etanercept treatment for children with refractory juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2011.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}